ArticleAnnals of medicine and surgery (2012)2024

Xolremdi (Mavorixafor): a breakthrough in WHIM syndrome treatment - unraveling efficacy and safety in a rare disease frontier.

Fatima Nadeem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.